FFAR4 and lung adenocarcinoma: Our experimental findings demonstrate that the activation of FFAR4 in lung adenocarcinoma cells leads to a noteworthy decline in the NAD+/NADH ratio and leads to dysfunction of OXPHOS, disrupting cellular energy balance and slowing down the proliferation of lung adenocarcinoma cells.